The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
NCT Number: NCT03741803
The purpose of the study is to determine if neonates (who already have an increased risk of hyperbilirubinemia due to mother's history of having previous neonate who received phototherapy for hyperbilirubinemia) have higher bilirubin levels 24 hours after birth with delayed cord clamping.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Houston, Texas, 77030, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The umbilical cord will be clamped after 60 seconds after birth
The umbilical cord will be clamped as soon as feasible after birth, usually within the initial 15 seconds after birth.
Time frame: 24 hours after birth
Time frame: 24 hours after birth
Hyperbilirubinemia is a condition in which there is too much bilirubin in the blood.
Time frame: From birth to up to 1 week after birth
Time frame: From birth to up to 1 week after birth
Time frame: From birth to up to 1 week after birth
Time frame: From birth to up to 1 week after birth
Time frame: From birth to up to 1 week after birth
The University of Texas Health Science Center, Houston
Other
Randomized Controlled Trial to Evaluate the Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04182555
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease
Haugesund, Norway
View Trial DetailsNCT03007563
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease
Oslo, Norway
View Trial DetailsNCT01887327
Anemia, Anemia, Hemolytic
Colton, California, United States
View Trial DetailsNCT00114543
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial Details